TIANTI BIOTHERAPEUTICS

tianti-biotherapeutics-logo

TianTi Biotherapeutics is a biotechnology company that provides research and development of antibody drugs.

#SimilarOrganizations #Financial #Website #More

TIANTI BIOTHERAPEUTICS

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2021-01-01

Address:
Woburn, Massachusetts, United States

Country:
United States

Website Url:
http://www.ttibio.com

Status:
Active

Contact:
+1 781-410-3200

Email Addresses:
[email protected]

Total Funding:
15.6 M USD


Similar Organizations

Investors List

shanghai-biomedical-industrial-equity-investment-fund_image

Shanghai Biomedical Industrial Equity Investment Fund

Shanghai Biomedical Industrial Equity Investment Fund investment in Series A - TianTi Biotherapeutics

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series A - TianTi Biotherapeutics

guangzhou-yuexiu-industrial-investment-fund_image

Guangzhou Yuexiu Industrial Investment Fund

Guangzhou Yuexiu Industrial Investment Fund investment in Series A - TianTi Biotherapeutics

oriza-holdings_image

Oriza Holdings

Oriza Holdings investment in Series A - TianTi Biotherapeutics

cathaycapital_image

Cathay Capital

Cathay Capital investment in Venture Round - TianTi Biotherapeutics

Official Site Inspections

http://www.ttibio.com

  • Host name: box5450.bluehost.com
  • IP address: 162.241.217.27
  • Location: Provo United States
  • Latitude: 40.2342
  • Longitude: -111.6442
  • Metro Code: 770
  • Timezone: America/Denver
  • Postal: 84606

Loading ...

More informations about "TianTi Biotherapeutics"

Home - TianTi Biotherapeutics

TianTi Biotherapeutics' AbLink™, OptAb™ and Rapid VHH technology platforms significantly improve hit success rates. These technologies are engineered to deliver fast, high-quality results for challenging targets.See details»

Company - TianTi Biotherapeutics

Our Company Company Overview TianTi Biotherapeutics is a preclinical stage biotech company. Our solutions are driven by rigorous data and teamwork. As a next-generation technology …See details»

TianTi Biotherapeutics - Crunchbase Company Profile …

Organization. TianTi Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... Contact Email …See details»

Tianti Biotherapeutics Inc. hiring Senior /Principal Scientist in ...

Tianti Bio Inc. is a preclinical stage company dedicated to developing cutting-edge antibody therapeutics for patients with unmet medical needs through our innovative drug discovery …See details»

Tianti Biotherapeutics - PitchBook

Tianti Biotherapeutics General Information Description. Developer of a drug discovery platform designed to develop target research and antibody drugs. …See details»

TianTi Biotherapeutics - 2025 Company Profile - Tracxn

Mar 31, 2025 LinkedUp, TianTi end legal dispute with Adimab over yeast-based antibody platformEndPoints News • Jan 10, 2024 • LinkedUp Bioscience, ttibio.com LinkedUp …See details»

TianTi Biotherapeutics - Drug pipelines, Patents, …

Explore TianTi Biotherapeutics with its drug pipeline, therapeutic area, technology platform, 2 news.See details»

Suzhou TIANTI Biomedical Co., Ltd. - Drug pipelines, Patents, …

Explore Suzhou TIANTI Biomedical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Antibody ...See details»

Tianti Biotherapeutics - MassBio

Massachusetts Biotechnology Council. 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100See details»

TianTi Biotherapeutics - Company Information, Competitors, News …

Find useful insights on TianTi Biotherapeutics's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at TianTi …See details»

Home - TianTi Biotherapeutics

TianTi Bio opens new doors for therapeutic discovery. We provide deep mining of the entire natural immune repertoire at unprecedented scale and sensitivity resulting in greater scientific success.See details»

Technology - TianTi Biotherapeutics

Our Technology TianTi Bio Beats the Antibody Challenge Antibody discovery can be one of medical research’s greatest challenges. TianTi Bio offers new confidence in antibody …See details»

Greg (Geqiang) Li - LinkedIn

Check out professional insights posted by Greg (Geqiang) Li, Founder & President, LinkedUp Bioscience Inc Founder & president, Tianti BiotherapeuticsSee details»

Suzhou TIANTI Biomedical Co., Ltd. (Suzhou TIANTI Biomedical …

了解Suzhou TIANTI Biomedical Co., Ltd. (Suzhou TIANTI Biomedical Co., Ltd.)公司的药物管线,治疗领域,技术平台,以及它的4篇新闻,疾病领域:肿瘤,技术平台:双特异性抗体,抗体, …See details»

Branding Band on LinkedIn: Home - TianTi Biotherapeutics

Home - TianTi Biotherapeutics. Can you say 'Aggregation Analysis Expression' 5 times fast? Thank you to the masters of differentiated antibodies, Tianti Biotherapeutics, for sharing their …See details»

LinkedUp Bioscience and TianTi Biotherapeutics Successfully …

Jan 9, 2024 For further information: Greg Li TianTi Biotherapeutics Inc Tel: 781-410-3200, ext 101 Email: [email protected] Release Summary LinkedUp Bioscience and TianTi Biotherapeutics …See details»

TianTi Biotherapeutics-Overview, Competitors & Contact Info

Get TianTi Biotherapeutics’s (ttibio.com) location in null China, revenue, industry, competitors, technographics and contact information. Find and reach similar companies by location, …See details»

News - TianTi Biotherapeutics

Woburn, Massachusetts, Jan 9th, 2024 LinkedUp Bioscience and TianTi Biotherapeutics Successfully Resolve Legal Dispute with Adimab LinkedUp Bioscience and TianTi …See details»

LinkedUp Bioscience and TianTi Biotherapeutics Successfully …

Jan 9, 2024 WOBURN, Mass.--(BUSINESS WIRE)-- LinkedUp Bioscience and TianTi Biotherapeutics are pleased to announce the resolution of the lawsuit brought by Adimab, …See details»

LinkedUp Bioscience and TianTi Biotherapeutics Successfully …

WOBURN, Mass., January 09, 2024--LinkedUp Bioscience and TianTi Biotherapeutics Successfully Resolve Legal Dispute with AdimabSee details»

linkstock.net © 2022. All rights reserved